@aminextx.com
Aminex Therapeutics develops small molecule based cancer treatment solutions.
π’
Find anything inaccurate?
If you spot any mistakes on this brand profile, report to us.
Brand Logos
View allNo logo added yet.
About
Description
Aminex Therapeutics, Inc. At the core of their approach lies the ground-breaking Science Polyamine Depletion Therapy, which works to significantly reduce the levels of polyamines β molecules found abundantly in cancer cells and the tumor microenvironment β that actively suppress the immune system. By targeting both sources of polyamines, Aminex Therapeutics empowers the innate immune system to launch a potent assault against solid tumors.
Their flagship drug candidate, AMXT 1501 + DFMO, is an oral, small molecule therapy that combines their patented polyamine uptake inhibitor, AMXT 1501, with DiFluoroMethylOrnithine (DFMO), a well-established polyamine synthesis inhibitor. This synergistic combination unlocks a powerful immune system therapy that holds immense potential for a wide range of solid tumor cancers. Stay updated with the latest breakthroughs from Aminex Therapeutics as they strive to revolutionize cancer treatment and save lives
Brand collections
View allLogos
Colors
Fonts
Images
Our mission is to keep every brand on-brand everywhere π
All services online
Top brand categories